PEDIATRIC PUZZLER: An ataxic teen with rapidly changing eye findings

Addictive use of screens—not total time—was linked to higher risks of suicidal behavior and mental health issues in early adolescents.

Lenacapavir is the first twice-yearly option available in the US for those who need or want PrEP, according to Gilead Sciences.

Currently, omaveloxolone (Skyclarys) is approved to treat adults and adolescents aged 16 years and older impacted by FA.

The American Academy of Pediatrics urges clinicians to offer confidential, adolescent-centered contraceptive care using evidence-based, equity-informed approaches.